Mr. Michael Billard came to APT in September 2020 following a twenty-year career in biotech, pharma, and consumer product development. He has held senior leadership roles at Propella Therapeutics, Inc., Vizuri Health Sciences, Paragon Bioservices, and DSM Nutritional Products (formerly Martek BioSciences) along with project management positions at MedImmune, Inc. and Baxter Healthcare Corporation. Mr. Billard earned his Master of Science in Biotechnology from Johns Hopkins University.